Email Alert RSS
Volume 15 Issue 1
Jan.  2024
Turn off MathJax
Article Contents
Abstract
References
QIN Jing, ZHU Qingli. Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 130-134. DOI: 10.12290/xhyxzz.2023-0306
Citation: QIN Jing, ZHU Qingli. Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(1): 130-134. DOI: 10.12290/xhyxzz.2023-0306
shu

Early Efficacy Assessment of Targeted Therapy for Crohn's Disease by Ultrasound

  • 1.

    Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

National High-Level Hospital Clinical Research Funding 2022-PUMCH-C-018

National Natural Science Foundation of China 81791640

More Information
  • Corresponding author:

    ZHU Qingli, E-mail: zqlpumch@126.com

  • Received Date: June 26, 2023
  • Accepted Date: July 30, 2023
  • Issue Publish Date: January 29, 2024
    Graphical Abstract
    • Abstract
  • Crohn's disease (CD) is a chronic inflammatory bowel disease with complicated pathogenesis and prolonged condition. In recent years, with the development of targeted therapy, biological agents have been widely used in the treatment of CD, which has significantly improved the prognosis of CD patients. If the efficacy evaluation can be carried out at the early stage of targeted therapy, it may help to figure out the patients who can benefit from the treatment and optimize the treatment plan for the ineffective patients in time. In the evaluation of CD activity and efficacy, ultrasound has the advantages of high accuracy, no radiation and high patient acceptance, and therefore has potential clinical application value in the early efficacy evaluation of CD targeted therapy. This article reviews the research progress to provides a reference for optimizing the treatment plan for CD patients.
    • FullText(HTML)
    • References (22)
  • [1]
    Lichtenstein G R, Loftus E V, Isaacs K L, et al. ACG clinical guideline: management of Crohn's disease in adults[J]. Am J Gastroenterol, 2018, 113(4): 481-517. DOI: 10.1038/ajg.2018.27
    [2]
    Ilvemark J F K F, Hansen T, Goodsall T M, et al. Defining transabdominal intestinal ultrasound treatment response and remission in inflammatory bowel disease: systematic review and expert consensus statement[J]. J Crohns Colitis, 2022, 16(4): 554-580. DOI: 10.1093/ecco-jcc/jjab173
    [3]
    Drews B H, Barth T F E, Hänle M M, et al. Comparison of sonographically measured bowel wall vascularity, histo-logy, and disease activity in Crohn's disease[J]. Eur Radiol, 2009, 19(6): 1379-1386. DOI: 10.1007/s00330-008-1290-5
    [4]
    Novak K L, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score[IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn's disease[J]. J Crohns Colitis, 2021, 15(4): 609-616. DOI: 10.1093/ecco-jcc/jjaa216
    [5]
    Dragoni G, Gottin M, Innocenti T, et al. Correlation of ultrasound scores with endoscopic activity in Crohn's disease: a prospective exploratory study[J]. J Crohns Colitis, 2023, 17(9): 1387-1394. DOI: 10.1093/ecco-jcc/jjad068
    [6]
    Bots S, Nylund K, Löwenberg M, et al. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores[J]. J Crohns Colitis, 2018, 12(8): 920-929. DOI: 10.1093/ecco-jcc/jjy048
    [7]
    Goodsall T M, Nguyen T M, Parker C E, et al. Systematic review: gastrointestinal ultrasound scoring indices for inflammatory bowel disease[J]. J Crohns Colitis, 2021, 15(1): 125-142. DOI: 10.1093/ecco-jcc/jjaa129
    [8]
    Castiglione F, Mainenti P, Testa A, et al. Cross-sectional evaluation of transmural healing in patients with Crohn's disease on maintenance treatment with anti-TNF alpha agents[J]. Dig Liver Dis, 2017, 49(5): 484-489. DOI: 10.1016/j.dld.2017.02.014
    [9]
    Castiglione F, Testa A, Rea M, et al. Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics[J]. Inflamm Bowel Dis, 2013, 19(9): 1928-1934.
    [10]
    Orlando S, Fraquelli M, Coletta M, et al. Ultrasound elasticity imaging predicts therapeutic outcomes of patients with Crohn's disease treated with anti-tumour necrosis factor antibodies[J]. J Crohns Colitis, 2018, 12(1): 63-70. DOI: 10.1093/ecco-jcc/jjx116
    [11]
    De Voogd F, Bots S, Gecse K, et al. Intestinal ultrasound early on in treatment follow-up predicts endoscopic response to anti-TNFα treatment in Crohn's disease[J]. J Crohns Colitis, 2022, 16(10): 1598-1608. DOI: 10.1093/ecco-jcc/jjac072
    [12]
    Calabrese E, Rispo A, Zorzi F, et al. Ultrasonography tight control and monitoring in Crohn's disease during different biological therapies: a multicenter study[J]. Clin Gastroenterol Hepatol, 2022, 20(4): e711-e722. DOI: 10.1016/j.cgh.2021.03.030
    [13]
    Paredes J M, Moreno N, Latorre P, et al. Clinical impact of sonographic transmural healing after anti-TNF antibody treatment in patients with Crohn's disease[J]. Dig Dis Sci, 2019, 64(9): 2600-2606. DOI: 10.1007/s10620-019-05567-w
    [14]
    Kucharzik T, Wittig B M, Helwig U, et al. Use of intestinal ultrasound to monitor Crohn's disease activity[J]. Clin Gastroenterol Hepatol, 2017, 15(4): 535-542. e2. DOI: 10.1016/j.cgh.2016.10.040
    [15]
    Ripollés T, Paredes J M, Martínez-Pérez M J, et al. Ultrasonographic changes at 12 weeks of anti-TNF drugs predict 1-year sonographic response and clinical outcome in Crohn's disease: a multicenter study[J]. Inflamm Bowel Dis, 2016, 22(10): 2465-2473. DOI: 10.1097/MIB.0000000000000882
    [16]
    Paredes J M, Ripollés T, Cortés X, et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's Disease[J]. Dig Dis Sci, 2010, 55(2): 404-410. DOI: 10.1007/s10620-009-0759-7
    [17]
    Goertz R S, Klett D, Wildner D, et al. Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study[J]. Acta radiol, 2018, 59(10): 1149-1156. DOI: 10.1177/0284185117752032
    [18]
    Quaia E, Sozzi M, Angileri R, et al. Time-intensity curves obtained after microbubble injection can be used to differentiate responders from nonresponders among patients with clinically active Crohn disease after 6 weeks of pharmacologic treatment[J]. Radiology, 2016, 281(2): 606-616. DOI: 10.1148/radiol.2016152461
    [19]
    Quaia E, Gennari A G, Cova M A. Early predictors of the long-term response to therapy in patients with Crohn disease derived from a time-intensity curve analysis after microbub-ble contrast agent injection[J]. J Ultrasound Med, 2019, 38(4): 947-958. DOI: 10.1002/jum.14778
    [20]
    Saevik F, Nylund K, Hausken T, et al. Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease[J]. Inflamm Bowel Dis, 2014, 20(11): 2029-2037. DOI: 10.1097/MIB.0000000000000159
    [21]
    Baumgart D C, Müller H P, Grittner U, et al. US-based real-time elastography for the detection of fibrotic gut tissue in patients with stricturing Crohn disease[J]. Radiology, 2015, 275(3): 889-899.
    [22]
    Chen Y J, Chen B L, Liang M J, et al. Longitudinal bowel behavior assessed by bowel ultrasound to predict early response to anti-TNF therapy in patients with Crohn's disease: a pilot study[J]. Inflamm Bowel Dis, 2022, 28(Suppl 2): S67-S75.
    • Related Articles

  • Cited by

    Periodical cited type(7)

    1. 李娜，刘洋，李玉乐，董哲，赵娜，李慧文，李洁. 借助新媒体提高临床实践指南传播力：《协和医学杂志》的探索与实践. 中国科技期刊研究. 2024(05): 658-663 .
    2. 宋再伟，赵荣生，陈耀龙，徐东. 基于高质量循证用药指南制定与实施的临床药学“实践-研究一体化”模式构建与实践. 中国临床药学杂志. 2024(06): 401-407 .
    3. 罗旭飞，吕晗，宋再伟，刘辉，王郅翔，李昊东，王晔，朱迪，张璐，陈耀龙. 生成式人工智能对临床实践指南制订、评价和应用的影响. 协和医学杂志. 2024(05): 1173-1181 . 本站查看
    4. 耿一雄，张宇轩，赵星媛，朱娜，张超，王雨嘉，焦莉平，刘雅莉. 儿科住培生指南知晓依从情况及影响因素的调查研究. 中国循证心血管医学杂志. 2024(12): 1424-1428+1434 .
    5. 赖鸿皓，孙铭谣，黄嘉杰，李颖，宁金铃，赵威龙，唐文静，杨水华，田金徽，陈耀龙，商洪才，杨克虎，葛龙. 中西医结合临床实践指南实施框架构建的思考. 协和医学杂志. 2023(01): 31-38 . 本站查看
    6. 李晓清，曹永茂. 医学期刊编辑提升临床实践指南质量的策略. 编辑学报. 2023(04): 399-403 .
    7. 陈耀龙，刘辉，姚志荣，高兴华. 提升皮肤病领域指南和共识质量的策略与建议. 中华皮肤科杂志. 2023(09): 805-808 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (290) PDF downloads (55) Cited by(9)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close